Cargando…

Ideal benznidazole dose regimen in chronic chagasic patients: a systematic review

The present study aimed to review the existing literature and to evaluate the best dose regimen for benznidazole in adult patients with Chagas disease in the chronic phase. A systematic review was conducted followed by meta-analysis. Searches were performed in four databases, to include studies publ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Frade, Virgínia Paula, Simões, Nathália Soares, Couto, Nayara Ragi Baldoni, Sanches, Cristina, Oliveira, Cláudia Di Lorenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Instituto de Medicina Tropical 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7384592/ https://www.ncbi.nlm.nih.gov/pubmed/32725057 http://dx.doi.org/10.1590/S1678-9946202062052

Ejemplares similares

Ideal benznidazole dose regimen in chronic chagasic patients: a systematic review
Publicado: (2020)

Benznidazole Treatment of Chagasic Encephalitis in Pregnant Woman with AIDS
por: Bisio, Margarita, et al.
Publicado: (2013)

Population pharmacokinetic modeling of benznidazole in Brazilian patients with chronic Chagas disease
por: Frade, Virgínia Paula, et al.
Publicado: (2022)

Short-term follow-up of chagasic patients after benznidazole treatment using multiple serological markers
por: Fernández-Villegas, Ana, et al.
Publicado: (2011)

Benznidazole
por: Soares-Sobrinho, José Lamartine, et al.
Publicado: (2008)

Biomarkers of severity and chronification in chikungunya fever: a systematic review and meta-analysis
por: Ferreira, Andreia Silva, et al.
Publicado: (2021)

Stroke Correlates in Chagasic and Non-Chagasic Cardiomyopathies
por: da Matta, José Alberto Martins, et al.
Publicado: (2012)

Benznidazole Treatment: Time- and Dose-Dependence Varies with the Trypanosoma cruzi Strain
por: Fonseca, Kátia da Silva, et al.
Publicado: (2021)

Quality of life in patients with Chagas disease and the instrument used: an integrative review
por: Baldoni, Nayara Ragi, et al.
Publicado: (2021)

Role of FAK signaling in chagasic cardiac hypertrophy
por: Tucci, Amanda R., et al.
Publicado: (2020)

Benznidazole, itraconazole and their combination in the treatment of acute experimental Chagas disease in dogs
por: Cunha, Eleonora Lima Alves, et al.
Publicado: (2019)

Constipation Is Related to Small Bowel Disturbance Rather Than Colonic Enlargement in Acquired Chagasic Megacolon
por: Bafutto, Mauro, et al.
Publicado: (2017)

Preclinical pharmacokinetics of benznidazole.
por: Workman, P., et al.
Publicado: (1984)

Chagasic megacolon: enteric neurons and related structures
por: Jabari, Samir, et al.
Publicado: (2014)

Left Atrial Function in Patients with Chronic Chagasic Cardiomyopathy
por: Fragata, Claudia da Silva, et al.
Publicado: (2015)

Suprahyoid Muscle Activity in Patients with Chagasic Megaesophagus
por: El Gharib, Aretuza Zaupa Gasparim, et al.
Publicado: (2019)

Quality of clinical studies present in the package inserts of coagulation factors used in the treatment of hemophilia
por: Araújo, Yasmin Gonçalves, et al.
Publicado: (2022)

Drug transporter and oxidative stress gene expression in human macrophages infected with benznidazole-sensitive and naturally benznidazole-resistant Trypanosoma cruzi parasites treated with benznidazole
por: Téllez, Jair, et al.
Publicado: (2019)

Benznidazole Use among Patients with Chronic Chagas' Cardiomyopathy in an Endemic Region of Brazil
por: Ferreira, Ariela Mota, et al.
Publicado: (2016)

Chagas disease and perceived quality of life: a cross-sectional study
por: Baldoni, Nayara Ragi, et al.
Publicado: (2023)

Chromosomal imbalances are uncommon in chagasic megaesophagus
por: Bellini, Marilanda F, et al.
Publicado: (2010)

Cardiac condition in young chagasic women
por: Lassen, O, et al.
Publicado: (2013)

Chagasic meningoencephalitis after heart transplant
por: Hernández, Jenny Paola Garzón, et al.
Publicado: (2021)

Partial, selective survival of nitrergic neurons in chagasic megacolon
por: Jabari, Samir, et al.
Publicado: (2010)

Towards an ideal antiretroviral regimen for the global HIV epidemic
por: Grinsztejn, Beatriz, et al.
Publicado: (2017)

Sympathetic Dysautonomia in Heart Failure by (123)I-MIBG: comparison between Chagasic, non-Chagasic and heart transplant patients
por: Marino, Viviane Santuari Parisotto, et al.
Publicado: (2018)

Molecular characterization of the hexose transporter gene in benznidazole resistant and susceptible populations of Trypanosoma cruzi
por: dos Santos, Paula F, et al.
Publicado: (2012)

A protocol update for the Selenium Treatment and Chagasic Cardiomyopathy (STCC) trial
por: Holanda, Marcelo Teixeira, et al.
Publicado: (2018)

Stem Cell-Based Therapies in Chagasic Cardiomyopathy
por: Campos de Carvalho, Antonio Carlos, et al.
Publicado: (2015)

Chemotherapeutic Efficacy of Phosphodiesterase Inhibitors in Chagasic Cardiomyopathy
por: Wen, Jian-jun, et al.
Publicado: (2016)

Analysis of Iron Metabolism in Chronic Chagasic Cardiomyopathy
por: Miranda, Carla Paixão, et al.
Publicado: (2019)

Prognostic Factors in Severe Chagasic Heart Failure
por: Costa, Sandra de Araújo, et al.
Publicado: (2017)

Electrophysiological study in chagasics with syncope and conduction disorder
por: Dreicon, Alexia Hallack, et al.
Publicado: (2023)

Effects of Cholinergic Stimulation with Pyridostigmine Bromide on Chronic Chagasic Cardiomyopathic Mice
por: de Cuba, Marília Beatriz, et al.
Publicado: (2014)

Elucidating the impact of low doses of nano-formulated benznidazole in acute experimental Chagas disease
por: Rial, Marcela S., et al.
Publicado: (2017)

Benznidazole Biotransformation and Multiple Targets in Trypanosoma cruzi Revealed by Metabolomics
por: Trochine, Andrea, et al.
Publicado: (2014)

Beneficial effects of benznidazole in Chagas disease: NIH SaMi-Trop cohort study
por: Cardoso, Clareci Silva, et al.
Publicado: (2018)

Evaluation of the properties of WHODAS-12 measurements in individuals with Chagas disease in Brazil
por: Tavares, Patrícia Aparecida, et al.
Publicado: (2023)

From Benznidazole to New Drugs: Nanotechnology Contribution in Chagas Disease
por: Gomes, Daniele Cavalcante, et al.
Publicado: (2023)

Reporting of adverse reactions to benznidazole: does medical expertise matter?
por: Pereiro, Ana Cristina, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fo20tofd9a59cjquo0lr9bk70m